»ªÖпƼ¼´óѧͬ¼ÃҽѧԺ2003Äê¹¥¶Á²©Ê¿Ñ§Î»Ñо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ l_
/q/8-l
We]mm3M3
¿¼ÊÔ¿ÆÄ¿£ºÒ½Ñ§ÃâÒßѧ£¨»ù´¡¿Î£©¿ÆÄ¿´úÂ룺806
FOz7W
Hk)IV"[R
Ò»Ãû´Ê½âÊÍ£¨¹²5Ì⣬ÿÌâ4·Ö£¬¹²20·Ö£© *z-Mr~V
1.Antigen presenting cell£¨APC£©
XI+m
2.Activation induced cell death£¨AICD£©
tz{W69k+
3.Chemokine Un{hI`3]
4.Major histocompatibility complex£¨MHC£© G 2L?j
5.immunotolerance 4c
"x&x|
vMBF7Jfx
¶þÎÊ´ðÌ⣨¹²5Ì⣬ÿÌâ10·Ö£¬¹²50·Ö£© 1_}*
aQ
1.ÊÔÊö²ÎÓëThϸ°ûÓëBϸ°ûÏ໥¼¤»îµÄ·Ö×Ó¼°¸÷×ԵŦÄÜ $2l<X KT-
2.ºÎν𤸽·Ö×Ó£¿¼òÊö𤸽·Ö×ӵķÖÀ༰ÆäÔÚÃâÒßÖеÄ×÷Óà hdZ{8 rP
3.¼òÊöIIÐͳ¬Ãô·´Ó¦µÄ·¢Éú»úÖÆ YcJZG|[
4.ÔÚÕý³£Çé¿öÏ£¬ÃâÒßϵͳ¶Ô×ÔÉí¿¹Ô²»²úÉúÃâÒßÓ¦´ðµÄ»úÖÆÊÇʲô£¿ fI:j@Wug
5.±È½ÏCTLºÍNKɱÉ˰Ðϸ°ûʱʶ±ðºÍɱÉË»úÖÆµÄÌØµã Q2wEt
>0a
p
BU,"Yy&
ÈýÑ¡´ðÌ⣨µÚ1Ìâ±Ø´ð£¬2ºÍ3ÌâÈÎÑ¡1Ì⣬ÿÌâ15·Ö£¬¹²30·Ö£© 5&}~W)"9
1.¼òÊöÒÆÖ²ÅųⷴӦÖÐÊÜÕßTϸ°û¶ÔͬÖÖÒìÌ忹ԵÄʶ±ð»úÖÆ¡£Í¨¹ýÖ±½Óʶ±ð¼¤»îµÄÊÜÕßThϸ°ûºÍTcϸ°û·Ö±ðÔÚ¸¨ÖúÊÜÕßBϸ°ûºÍɱÉËÒÆÖ²Îï·½ÃæÓë¼ä½Óʶ±ð¼¤»îµÄThºÍTcÓкβîÒ죿Ϊʲô£¿ :q6j{C(
2.½áºÏÄãµÄרҵÊÔÊöϸ°ûÒò×ÓÔÚ¼²²¡·¢Éú·¢Õ¹ÖеÄ×÷Óã¬Ä㽫²ÉÈ¡ÄÄЩ²ßÂÔÕë¶ÔÕâЩ°ÐµãÖÎÁƼ²²¡£¿ !)1r{u
3.ºÎΪ»ùÒò¹¤³Ì¿¹Ì壿Ŀǰ¹úÄÚÍâÔÚ»ùÒò¹¤³Ì¿¹ÌåÑо¿ÖÐÓÐÄÄЩÖ÷Òª½øÕ¹£¿ KjK.Sv{N
O5^!\j.WR
»ªÖпƼ¼´óѧͬ¼ÃҽѧԺ2003Äê¹¥¶Á²©Ê¿Ñ§Î»Ñо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ +:@lde]/p
sC
,[CN:b
¿¼ÊÔ¿ÆÄ¿£ºÒ½Ñ§ÃâÒßѧ£¨×¨Òµ¿Î£©¿ÆÄ¿´úÂ룺906 E3IB> f
M<'AM4
Ò»Ãû´Ê½âÊÍ£¨4·Ö/Ì⣩ tqdw
y.
1.Antigenic determinant ]xhZJ~"@u
2.IgSF y7)s0g>%H
3.MBL;¾¶ /yRP>CX~
4.chemokine udCum4
5.HLA¸´ºÏÌåµÄ¶à»ùÒòÐÔÓë¶àëÄÐÔ u} y)'eH
6.TCR-CD3¸´ºÏÎï CxyL'k
7.FADD£¨Fas-associated protein with death domain£© p#['CqP8
8.AIDS :el]IH
9.Tumor rejection antigen #
tN#_<W
10.AICD >]DnEF&
:Taequ
k
¶þÎÊ´ðÌ⣨15·Ö/Ì⣩ AQCU\E
1.¼òÊöCD·Ö×ÓÔÚÃâÒßЧӦÖеÄ×÷Ó㨰´ÊÜÌå·ÖÀà¼òÊö£© a>1_|QB.
2.¼òÊöBϸ°û²ÎÓëµÄÃâÒß¹¦ÄÜ p-p]dV
3.¼òÊö×ÔÉíÃâÒßÐÔ¼²²¡Ê±Õë¶Ô×ÔÉí×éÖ¯²úÉúÃâÒßÓ¦´ðµÄ¿ÉÄÜ»úÖÆ Yh=/?&*
4.ºÎνͬÖÖÒìÐÍMHC¿¹ÔÖ±½Óʶ±ðºÍ¼ä½Óʶ±ð£¿¼òÊöÆäÒì ~_XJ v
+mc0:e{WF
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾Å¶þÄê¹¥¶Á˶ʿÑо¿ÉúÈëѧÊÔÌâ 8KQD
w:
%<4ZU!2L
|2oCEb1
רҵ¿Î ÃâÒßѧ %XIPPEHU
Ò»¡¢ ·Òë²¢½âÊÍÏÂÁÐÃû´Ê irg%n
1. Immunotoxin 2. T inducer 3. T cell receptor 4. Accessory cell y81B3`@
5. Fc¦Å receptor 6. Cytokine uif1)y`Q$C
¶þ¡¢ ÎÊ´ðÌâ gO
{XD.s
1. ÃâÒßϵͳÖУ¬ÄÄЩϸ°ûÄÜÌØÒì»ò·ÇÌØÒâÐÔµØÉ±É˰Ðϸ°û£¬ÊÔ·Ö±ð¼òÊöɱÉË×÷ÓõIJ»Í¬Ìص㡣 hj~nLgpN
2. ¸ù¾ÝT¡¢Bϸ°û±íÃæ±êÖ¾µÄ²»Í¬£¬¿ÉÒÔÓ¦ÓÃÄÄЩÃâÒßѧ¼¼Êõ¼ø±ðÕâÁ½Ààϸ°û£¬¼òÊöÓйصÄʵÑéÔÀí£¿ ]`p*ZTr)\
3. ÔÚIVÐͳ¬Ãô·´Ó¦ÖУ¬ÖÂÃôTϸ°ûÊÍ·ÅÄÄЩÁܰÍÒò×Ó²ÎÓëÃâÒßËðÉË£¬ÏêÊöÆä×÷ÓûúÀí¡£ U9uy(KOW
4. ÊÔÊöHLA¸´ºÏÌåµÄÒÅ´«Ìص㼰ÕâÐ©ÌØµãµÄÉúÎïѧÒâÒ壿 `%PU_;Y5Q
5. ºÎνµ¥¿Ë¡¿¹Ì壿ÏêÊöÆäÔÚ»ù´¡ÓëÁÙ´²Ò½Ñ§ÖеÄÓ¦Óᣠ4tv}5llSG
p>GTFXEi6
"JHdF&
5*Wo/%#q
G-vBJlt=t
TB!z:n
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾ÅÈýÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ 3k5C;5
dZSv=UY)
W7k0!Grrl
רҵ¿Î ÃâÒßѧ m2j&v$
Ò»¡¢ ·Òë²¢½âÊÍÏÂÁÐÃû´Ê DU@ZLk3
1¡¢ Complement receptor type ¢ñ 2¡¢ Serologically defined antigen %xa.{`}`U
3¡¢ Transfer factor 4¡¢ Immunotoxin 5¡¢ Perforin **].d;~[l
6¡¢ Arthus reaction 7¡¢ Network theoty 8.Lymphocyte transformation test ?9F_E+!
9. Hybridoma technic 10.Mitogen C(RZ09,.S
11.Dentritic cell 12.Immunoproliferation sYt\3/yL'
¶þ¡¢ »Ø´ðÏÂÁÐÎÊÌâ "s:eH"_s
1¡¢ ÍÌÊÉϸ°û¶Ôϸ¾úµÄÍÌÊɹý³Ì°üÀ¨ÄöÖ÷Òª½×¶Î£¬ÊÔÏêÊöÖ®¡£ dtXAEL\q
2¡¢ ÊÔÊöIL-2µÄϸ°ûÀ´Ô´¹¦Äܼ°ÁÙ´²Ó¦Óᣠ\]@XY_21
3¡¢ Ò©Îï»ò»¯Ñ§ÊÔ¼ÁÒýÆðµÄÒ©ÕîÊôÓÚʲôÐͳ¬Ãô·´Ó¦£¬ÊÔÊöÆä»úÀí¡£ (JgW")M`cY
4¡¢ ÌåÄÚµÄÃâÒß·Ö×Ó°üÀ¨Äļ¸ÀࣿÊÔ¼òÊö¸÷ÀàÃâÒß·Ö×ÓµÄÖ÷Òª¹¦ÄÜ¡£ "kYzgi
5¡¢ ºÎνÃâÒß±ê¼Ç¼¼Êõ£¿Ö÷ÒªÓÐÄļ¸ÀàÃâÒß±ê¼Ç¼¼Êõ£¿ÊÔ·Ö±ð¼òÊöËüÃǵÄÖ÷ÒªÔÀí¡£ ZQ&A'(tt4
1$Jria5n
47GL[ofY
RB\0o,mw4
Ezvm5~<
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾ÅËÄÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ H[cHF
\0{g~cU4
$p(,Qz(.8
רҵ¿Î ÃâÒßѧ }I1A4=d
Ò»¡¢ Ãû´Ê½âÊÍ QNGICG-
1¡¢ ³Ù·¢Ðͱä̬·´Ó¦Tϸ°û 2¡¢ C1ÒÖÖÆÎï YY&3M
3¡¢ ¼¯Âä´Ì¼¤Òò×Ó 4¡¢ ¿¹ÔÌá³Ê×÷Óà ,b&-o?.{
5¡¢ HIAÓë¼²²¡µÄ¹ØÁª 6¡¢ Ë«¹¦ÄÜ¿¹Ìå 7¡¢ ÃâÒßÄÍÊÜ dG}.T_l
¶þ¡¢ ÎÊ´ðÌâ j.'Rm%@u
1¡¢ TÁܰÍϸ°û¾ßÓÐÄÄЩ±íÃæ±êÖ¾£¿ÊÔÊö¸÷±íÃæ±êÖ¾µÄÉúÎïѧ×÷Óü°/»òÒâÒå¡£ sSh=Idrx
2¡¢ ÊÔÊöÒÆÖ²ÅųⷴӦµÄÃâÒßÓ¦´ð¹ý³Ì¼°²ÎÓëÅųⷴӦµÄÖÂÃôÁܰÍϸ°ûºÍЧӦÎïÖÊ¡£ ]m>N!Iu
3¡¢ ºÎνϸ°ûÒò×Ó£¿¼òÊöÆä¹²Í¬Ìص㼰ÓëÁÙ´²µÄ¹ØÏµ¡£ UL46%MFQ
\
4¡¢ ºÎνÁܰÍϸ°ûÔÓ½»Áö¼¼Êõ£¬ÊÔÊöÆäÔÀí¼°ÒâÒå¡£ N@o Ng}D&:
5¡¢ ºÎνÉúÎïËØ-Ç׺ÍËØÏµÍ³£¿ÊÔÊöÆäÓ¦ÓÃÓÚÃâÒß±ê¼Ç¼¼ÊõµÄÔÀí£¬ÒÔABC·¨ÎªÀý˵Ã÷Ö®¡£ Up(Jw-.
:X?bWxOJ
S$=e %c
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾ÅÎåÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ isdEs k#A.
RpAtd^I
oX2J2O
רҵ¿Î ÃâÒßѧ rvdhfM!-A
Ò»¡¢ ·Òë²¢½âÊÍÏÂÁÐÃû´Ê R)
%1GG4
1¡¢ SmIg 2¡¢ Graft-versus-host reaction GVHR <hYrcOt
3¡¢ Immunocompent cell ICC 4¡¢ Tumor-associated antigen TAA BUuU#e5
5¡¢ Cytokine 6¡¢ Immune tolerance 7¡¢ Biological responsw modifier BRM E^RPK{zO
¶þ¡¢ ÎÊ´ðÌâ xnyp'O8yk
1¡¢ ÃâÒßϵͳÄÚÆðɱÉËЧӦµÄϸ°ûÓÐÄÄЩ£¿ÊÔ¼òÊöÆäɱÉËЧӦµÄÌØµã¡£ %
d%KH9u
2¡¢ ºÎν¿¹ÌåµÄ¶àÑùÐÔ£¿¿¹ÌåµÄ¶àÑùÐÔ±íÏÖÔÚÄÄЩ·½Ã棿¼òÊö²úÉú¿¹Ìå¶àÑùÐÔµÄÔÀí¡£ jq4'=L$4
3¡¢ ÊÔÊö¢òÐÍÓë¢óÐͳ¬Ãô·´Ó¦·¢Éú»úÖÆµÄÒìͬµã¡£ ]^>#?yEA3
4¡¢ ºÎνMHC£¿ÊÔ¼òÊöÆä¹¦ÄÜ¡£ G)I lkA@
5¡¢ ºÎνÃâÒß±ê¼Ç¼¼Êõ£¿Ö÷ÒªÓÐÄļ¸ÀàÃâÒß±ê¼Ç¼¼Êõ£¬ÒÔø±ê¼Ç¼¼ÊõΪÀý¼òÊöÆäÖ÷ÒªÔÀí¡£ AYC22(
m&'z|eN
QQd%V#M?
U 0$?:C+?
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾ÅÁùÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ v{R:F
`7;I*|
a"!D @a
רҵ¿Î ÃâÒßѧ gFsnL*L0
Ò»¡¢ ·Òë²¢½âÊÍÏÂÁÐÃû´Ê ^:b%QO
1. IgSF 2. Fc 3. Flow cytometry 4. Adhesion molecule {
.z6J)?J2
5. Autogous mixed lymphoyte reaction e[3rz%'Q
¶þ¡¢ ÎÊ´ðÌâ 7qyv.{+
1. ÊÔÊöÍâÀ´TD¿¹Ô½øÈë»úÌåÓÕµ¼¿¹Ìå²úÉúµÄÈ«¹ý³Ì¡£ 4_`ss+gk
2. ºÎνϸ°ûÒò×Ó£¿¼òÊöIL-2µÄ¼ì²â·½·¨¼°ÆäÔÀí¡£ R+c
{Pl
3. ¼òÊö¿¹¶ÀÌØÐÍÍøÂçµÄµ÷¿Ø×÷Óᣠ.K`^n\T
t
4. ÃâÒßÓ¦´ð¶Ô»úÌåÓкÎÀûº¦¹ØÏµ£¿ =w~phn
lgxG:zAC
!wws9
va(ZGGS]N
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾ÅÆßÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ ;tS 4h
mkfU
fG&
=R M=@X
רҵ¿Î ÃâÒßѧ =H'7g6
[Z3B~c
XO)|l8t#$=
Ò»¡¢ ·Òë²¢½âÊÍÏÂÁÐÃû´Ê bK)gB!
1. Idiotupe 2. Opsonization 3. Epitope 4. Immunologic tolerance a95QDz
5. Delayed type hypersensitivity bDLPA27
¶þ¡¢ ÎÊ´ðÌâ A7~~{9
1. ÊÔÊö²¹Ì徵伤»î;¾¶ÓëÅÔ·¼¤»î;¾¶µÄÒìͬ¡£ ,0^:q)_
2. ¼òÊö¿¹ÌåµÄ»ù±¾½á¹¹£¨ÒÔIgGΪÀý£©Ó빦ÄÜ¡£ _,hhO
3. ¼òÊöHLAÓëҽѧµÄ¹ØÏµ¡£ g-c\;
4. ÊÔÊöµ¥ºË/¾ÞÊÉϸ°ûÔÚÃâÒßÓ¦´ðÖеÄ×÷Óᣠ\W<r`t4v
5. ¼òÊöÃâÒßÓ¦´ðÖи÷ÖÖÀàÐ͵Äϸ°û¶¾×÷ÓᣠM(,npW
4\%0a,\^
P^-
tGo!
m6P!#=a:l<
^L&hwXAO:
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾Å°ËÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ =sG9]a<I
D`=hP(y^
';buS -|6
רҵ¿Î ÃâÒßѧ nw3CI&Y`
Ò»¡¢ ·Òë²¢½âÊÍÏÂÁÐÃû´Ê K0xZZ`
1. hypersensitivity 2. cluster of differentiation pn6 e{
3. adhesion molecules 4. supper antigen 5. split tolerance dm60O8
¶þ¡¢ ÎÊ´ðÌâ pZRKM<k
1. ºÎνϸ°ûÒò×Ó£¿ÊÔÊöϸ°ûÒò×ÓµÄÖ÷ÒªÉúÎïѧ»îÐÔ¡£ 9}`A_KzFx
2. ¼òÊöMHC¿¹ÔµÄ·Ö×ӽṹ¼°Æä×éÖ¯·Ö²¼¡£ hSmu"a,S
3. ÊÔÊöÐØÏÙÒÀÀµÐÔ¿¹ÔÒýÆðÌåÒºÃâÒßÓ¦´ðµÄÈ«¹ý³Ì£¨°üÀ¨³õ´ÎÃâÒßÓ¦´ðºÍÔÙ´ÎÃâÒßÓ¦´ð£©¡£ m:77pE&o
4. Ϊʲô˵²¹Ì弤»î;¾¶Ö÷Òª²ÎÓëÌìÈ»ÃâÒߣ¿ÊÔÊö²¹ÌåÊÇÈçºÎ¾¹ýÅÔ·;¾¶¶ø±»¼¤»îµÄ¡£ ;C8'7
5. Ϊʲô¿¹Ä³Ò»Ï¸°ûÒò×ÓÊÜÌåµÄµ¥¿Ë¡¿¹ÔÌ壬ÓбíÏÖ³öÊÜÌå·â±Õ×÷Ó㬶øÓеÄÔò±íÏÖ³öÊÜÌå´Ì¼¤×÷Óã¿ \2!v~&S
vb{+yEa
i[b?W$]7
v%|()Z0
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾Å¾ÅÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ 4'pg>
;*.
רҵ¿Î ÃâÒßѧ c43"o
Ò»¡¢ Ãû´Ê½âÊÍ H4'xxsx
1. ¿¹ÔÐÔ 2. ÃâÒßÇòµ°°×³¬¼Ò×å 3. ¶ÀÌØÐÍ 4. ¿¹Ô¾ö¶¨×å h<oQ9zW)
5. GVHR `jR;Rcz
C
¶þ¡¢ ÎÊ´ðÌâ YX+Da"\
1. Á½ÖÖ²¹Ì弤»î;¾¶µÄµ÷½ÚÒò×ÓÓÐÄÄЩ£¿±È½ÏËüÃÇÁ½ÖÖ;¾¶ÖеÄ×÷Óᣠ'vO+,-
2. ¢òÐͳ¬Ãô·´Ó¦µÄ»úÀíÌØµãÊÇʲô£¿¾Ù³öÈý¸ö¢òÐͳ¬Ãô·´Ó¦µÄÀý×Ó¡£ hS4Ljyeg
3. ÊÔÊöϸ°ûÒò×ÓµÄ×÷ÓÃÌØµã¡£ /IM5#M5~
4. Bcell½éµ¼µÄÌåÒºÃâÒßÓ¦´ðµÄ¹ý³Ì¡£ C[:Q?LE
5. MPSµÄÃâÒßѧ¹¦ÄÜ¡£ KOWx P47b
i]Or'L0c
#`5 M(
o
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾Å¾ÅÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ {#CyO
b4
jp2AU,Cl
]@bo; .
רҵ¿Î ÃâÒßѧ =:(8F*Q
Ò»¡¢Ãû´Ê½âÊÍ fSdv%$;Hc
1. ÃâÒßÇòµ°°×µÄ¶ÀÌØÐÍ 2. 𤸽·Ö×Ó 3. ÃâÒßÇòµ°°×³¬¼Ò×å IMzhEm
4. ¸ÉÈÅËØ 5. HLAµÄ¶à̬ÐÔ 6. ÐØÏÙÒÀÀµÐÔ¿¹Ô 7. ÃâÒßÄÍÊÜ (
q^umw
8. ËÙ·¢Ðͳ¬Ãô·´Ó¦ 9. µ¥¿Ë¡¿¹Ìå 10. ²¹Ì徵伤»î;¾¶ )+[IR
11. »ìºÏÁܰÍϸ°û·´Ó¦ 12. ÓÐË¿·ÖÁÑ GYot5iLg
Èý¡¢ ÎÊ´ðÌâ VmrW\rH@
1. ÊÔ¼òÊö¾ÞÊÉϸ°ûÌá³ÊTD¿¹ÔµÄ¹ý³Ì¡£ FA\gz?h
2. ÊÔ¼òÊöÒÆÖ²ÎËÞÖ÷·´Ó¦µÄ·¢Éú»úÖÆ fRJSo%
3. ÊÔÊö²¹ÌåµÄÖ÷ÒªÉúÎïѧ×÷Óà Rxld$@~-(]
4. ÒÔIgGΪÀý£¬ÊÔÊöÃâÒßÇòµ°°×·Ö×ӵĻù±¾½á¹¹ ^I9x@t
5. ÊÔÊöTϸ°ûµÄÖ÷Òª±íÃæ±êÖ¾¼°¹¦ÄÜ NL))!Pi
R,01.N( U
0q"&AxNsP
67 >*AL
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾Å¾ÅÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ s,ZJ?[/
7,ODh-?ez
^<xpp.
eY
רҵ¿Î ÃâÒßѧ [Z0 &`qz
Ò»¡¢Ãû´Ê½âÊÍ oQ@X}6B%S
1. Ig¶ÀÌØÐÍ 2. SAg 3. 𤸽·Ö×Ó 4. CSF 5. IgSF 6. Tϸ°û»î»¯µÄ´Ì¼¤·Ö×Ó ;5-Sn(G
7. HLAÓë¼²²¡µÄ¹ØÁª 8. ELISA 9. ÁܰÍϸ°ûµÄ±íÃæ±êÖ¾ nm66U4.@
Èý¡¢ ÎÊ´ðÌâ ~^=QBwDW8N
1. ¼òÊöTÁܰÍϸ°ûµÄ·ÖÀ༰¹¦ÄÜ£¿ t)XNS!6#]?
2. ¼òÊöHLAÍ»±äÌåµÄ»ùÒò×é³É¼°HLAµÄ¹¦ÄÜ£¿ `p9h$d
3. ¼òÊö»úÌå¶ÔÍâÔ´ÐÔ¿¹Ô£¨ÒìÎԣ©µÄ´¦Àí£¬ÈçIgÌá³Ê¹ý³Ì£¿ YVZm^@ZVV
4. ¼òÊö²¹ÌåÁ½ÖÖ¼¤»î;¾¶µÄ»ù±¾¹ý³Ì£¬²¢±È½Ï¶þÕßÒìͬ£¿ N5[QQtQ
5. ¼òÊöAIDSÖÐCD4+ϸ°û¼õÉٵĻúÖÆ£¿ cEO g
#)_4$<P*'
C/ow{MxA
~:
Dr]kt
Ab
-uK|<
99Äê˶ʿÑо¿ÉúÃâÒßѧÊÔÌâ hT9fqH
Ò»¡¢Ãû´Ê½âÊÍ FVsV
Y1
2¡¢ HLAµÄ¶à̬ÐÔ 3¡¢ 𤸽·Ö×Ó 4¡¢ ¶ÀÌØÐÍ 5¡¢ ¿¹ÔëÄתÔËÎï lM"@v
NgK
6¡¢ Ig³¬¼Ò×å 7¡¢ µòÍö 8¡¢ ÓÐË¿·ÖÁÑÔ 9¡¢ CD4·Ö×Ó py9(z`}
10¡¢ ³¬Ãô·´Ó¦ 11¡¢ ×ÔÉíÃâÒß²¡ >Rs:Fw|jro
¶þ¡¢ ÎÊ´ðÌâ _kl.zw%
1¡¢ ÊÔÊöÍâÔ´ÐÔ¿¹ÔºÍÄÚÔ´ÐÔ¿¹ÔÌá³ÊµÄ¹ý³Ì¡£ JadXd K=gE
2¡¢ ÊÔÊöBϸ°û½éµ¼µÄÔÙ´ÎÃâÒßÓ¦´ðµÄ¹ý³Ì¡£ X*1vIs;[@
3¡¢ ÊÔÊö·Ö×ÓˮƽµÄÃâÒßµ÷½Ú¡£ )nJs9}( 0
4¡¢ ÊÔÊö»ñµÃÐÔÃâÒßȱÏÝ×ÛºÏÕ÷£¨AIDS£©µÄ·¢²¡»úÖÆ¡£ 5`*S'W}\>
i,M<}e1
2000Äê˶ʿÑо¿ÉúÃâÒßѧÊÔÌâ { :'#Ts<
Ò»¡¢ Ãû´Ê½âÊÍ wqJ^tA!
1¡¢ µ÷Àí×÷Óà 2¡¢ 𤸽·Ö×Ó 3¡¢ ³¬¿¹Ô 4¡¢ ÃâÒßȱÏݲ¡ G+[hE|L
~y
5¡¢ FasÓëFasL 6¡¢ µ¥¿Ë¡¿¹Ìå 7¡¢ ÃâÒßÄÍÊÜ kJq8"Klg
8¡¢ ÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£© 9¡¢ Ö×ÁöÏà¹Ø¿¹Ô£¨TAA£© SaMg)s~B
10¡¢ ÒõÐÔÑ¡Ôñ ]re1$W#*
¶þ¡¢ ÎÊ´ðÌâ i&$L$zf,
1¡¢ ºÎνϸ°ûÒò×Ó£¿ÊÔÊöϸ°ûÒò×ӵĹ²Í¬Ìص㣿 yYwZZa1
2¡¢ ºÎνAPC¼°ÆäÖÖÀࣿ¼òÊöÍâÔ´ÐÔ¿¹ÔµÄÈÜøÌåÌá³Ê;¾¶£¿ IQf:aX
3¡¢ ¼òÊöϸ°ûÃâÒßÓ¦´ðµÄÁ½ÀàЧӦϸ°ûµÄЧӦ»úÖÆ£¿Ï¸°ûÃâÒßµÄÉúÎïѧÒâÒ壿 03L+[F&"?
4¡¢ ºÎνMHC£¿¼òÊöMHCµÄ¹¦ÄÜ£¿ AK%`EsI^
5¡¢ ºÎν×ÔÉíÃâÒß²¡£¿¼òÊö×ÔÉíÃâÒß²¡µÄ×éÖ¯ËðÉË»úÖÆ£¿. Eb{Zm<TP
xCz(qR
C,Q>OkSc
xDG8C39qrs
ͬ¼ÃÒ½¿Æ´óѧ2000Äê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ b/HhGA0
URdCV{@42
pZUckQ
רҵ¿Î ÃâÒßѧ {Y6U%HG{{r
Ò»¡¢½«ÏÂÁÐÓ¢Óïµ¥´Ê·Òë³ÉÖÐÎIJ¢Ãû´Ê½âÊÍ DKnjmZ:J|
1. Cytokines 2. adhesion molecules 3. graft versus host reaction A^nB!veh
4. immunologic tolerance 5. Opsonization G?)NDRM
Èý¡¢ ÎÊ´ðÌâ \/J>I1J
1. ʲôÊÇMHC£¿ÊÔÊöMHC-¢òÀà·Ö×ӵĽṹ¡¢¸÷²¿Î»¹¦ÄÜ£¬MHC-¢òÀà·Ö×ÓµÄ×éÖ¯·Ö²¼¼°ÆäÃâÒßѧ×÷ÓᣠN]udZhkn
2. ÓÐÄÄÈý´ú¿¹Ì壿ÊÔÊö¿¹Ì壨IgG£©µÄ»ù±¾½á¹¹¡¢¸÷²¿Î»¹¦Äܼ°ÕâÈý´ú¿¹ÌåµÄÌØÐÔ¡£ ]Qm$S5tU
3. ʲôÊÇ×ÔÉíÃâÒß²¡£¿ÊÔÊöÆä·¢²¡»úÖÆ¡£ w$8Su:g=
4. ÃâÒßϵͳɱÉ˰Ðϸ°ûµÄ·½Ê½¼°ÏàӦϸ°ûºÍ·Ö×ÓÓÐÄÄЩ£¿ÊÔÊöTc½éµ¼µÄϸ°ûÃâÒßÓ¦´ð¡£ jcD_<WSe
5. »úÌåµÄÃâÒßϵͳΪʲô¿ÉÒÔʶ±ð×Ô¼ººÍÒ켺£¿ÆäÖ÷Òª»úÖÆÊÇʲô£¿ N^z4I,GV(
Ndq/n21j
hAX@|G.
s:ig;zb
:@#9P
,"
-d5b,leC^
»ªÖпƼ¼´óѧͬ¼ÃҽѧԺ s)C5u;3!
Tq{+9+
9'+Eu)l:
2001ÄêÕÐÊÕ˶ʿÑо¿ÉúÈëѧרҵ¿Î¿¼ÊÔÊÔÌâ -!i1xR(;h
¿¼ÊÔ¿ÆÄ¿£ºÒ½Ñ§ÃâÒßѧ eA q/[(
Ò»¡¢ ½âÊÍÏÂÁÐÃû´Ê VF[$hs
1. C3b½éµ¼µÄµ÷Àí×÷Óà 2.Tϸ°û¼¤»îµÄµÚ¶þÐźÅ3.Th1ϸ°û 4.HLAµÄ¶à̬ÐÔ c
I K
5.C1ÒÖÖÆÎï 6.TCR¦Ã¦ÄTϸ°û7.³Ù·¢Ðͳ¬Ãô·´Ó¦ 8.Ç÷»¯ÐÔϸ°ûÒò×Ó9.ÃâÒßÇòµ°°×µÄÀà±ðת»¯ 10.ÔìѪ¸Éϸ°û kq|(t{@Rp
11.»î»¯ÓÕµ¼µÄϸ°ûËÀÍö X<G"GaL
¶þ¡¢ Çë»Ø´ðÏÂÁÐÎÊ´ð ayF+2(vch)
1. ºÎνµ¥¿Ë¡¿¹Ì壬¼òÊöÆäÖÆ±¸ÔÀí¡£ W
D 8
2. ¼òÊöTϸ°ûÔÚÐØÏÙÄڵķ¢Óý¹ý³Ì¡£ NzS(,F
3. ÃâÒßϸ°û±íÃæÖ÷ÒªÓÐÄļ¸Àà±íÃæ¿¹ÔºÍ±íÃæÊÜÌ壬¼òÊö¸÷Àà·Ö×ÓµÄÖ÷Òª¹¦ÄÜ¡££¨HLA¡¢CD¡¢AM¡¢CKR¡¢CR¡¢MitogenR¡¢TCR¡¢BCR¡¢FcR£© E$O-\)wY0
4. ÊԱȽÏTCR¸´ºÏÌåºÍBCR¸´ºÏÌå½á¹¹Ó빦ÄܵÄÒìͬ¡£ k Il!n
5. ÊԱȽϳ¬¿¹ÔÓëÆÕͨ¿¹ÔµÄÒìͬ¡£ F(h
jP
_EPfeh;
$[f-{B{>*
Cp"a,% b6u
hK]mnA[Y
,X`w/ 2O
»ªÖпƼ¼´óѧͬ¼ÃҽѧԺ |WP}y-Au
2001ÄêÕÐÊÕ˶ʿÑо¿ÉúÈëѧµ¥¶À¿¼ÊÔÊÔÌâ F/%M`?m"ie
¿¼ÊÔ¿ÆÄ¿£ºÃâÒßѧ + /+> :
L(RI4d
Ò»¡¢ Ãû´Ê½âÊÍ Gxh r0'
1. ¿¹Ô³ÊµÝ 2. µ÷Àí×÷Óà 3. ³Áµí·´Ó¦ 4. ×ÔÉíÃâÒß TXL!5,
X_
5. GVHR 6. ÔìѪ¸Éϸ°û 7. ¿Ë¡ѡÔñѧ˵ 8. Ir»ùÒò `\-<tk9
9. ³¬Ãô·´Ó¦ 10. ³¬¿¹Ô 7q%xF#mK=
¶þ¡¢ÎÊ´ðÌâ k~%j"%OB
11. ¼òÊö²¹ÌåµÄÅÔ·¼¤»î;¾¶ L;GkG! g
12. ¼òÊöT¡¢Bϸ°ûÌØÕ÷µÄ²îÒì G)8v~=Bv
13. ¼òÊöT¡¢Bϸ°û¿¹Ô¾ö¶¨´ØµÄ²îÒì A3mvd-k
14. ΪʲôÃâÒßÇòµ°°×¾ßÓп¹ÔÐÔ£¿ÊÔÊöÃâÒßÇòµ°°×µÄ¿¹ÔÐÔ¡£ /7N&4FrG
15. ʲôÊÇÖ×Áö¿¹Ô£¿ÊÔÊö»úÌåÕë¶ÔÖ×Áö¿¹Ô²úÉú¿¹Ö×ÁöÃâÒßÓ¦´ðµÄ»úÖÆ¡£ ;kDUQw
6?(yMSKa